Fintel reports that on April 18, 2023, HC Wainwright & Co. reiterated coverage of SenesTech (NASDAQ:SNES) with a Buy recommendation.
Analyst Price Forecast Suggests 6,325.20% Upside
As of April 7, 2023, the average one-year price target for SenesTech is $81.60. The forecasts range from a low of $80.80 to a high of $84.00. The average price target represents an increase of 6,325.20% from its latest reported closing price of $1.27.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for SenesTech is $6MM, an increase of 451.23%. The projected annual non-GAAP EPS is -$15.91.
What are Other Shareholders Doing?
FSMAX - Fidelity Extended Market Index Fund holds 81K shares representing 2.79% ownership of the company. In it's prior filing, the firm reported owning 82K shares, representing a decrease of 1.13%. The firm increased its portfolio allocation in SNES by 11.24% over the last quarter.
FCFMX - Fidelity Series Total Market Index Fund holds 7K shares representing 0.23% ownership of the company. No change in the last quarter.
FNCMX - Fidelity Nasdaq Composite Index Fund holds 32K shares representing 1.09% ownership of the company. No change in the last quarter.
What is the Fund Sentiment?
There are 4 funds or institutions reporting positions in SenesTech. This is a decrease of 20 owner(s) or 83.33% in the last quarter. Average portfolio weight of all funds dedicated to SNES is 0.00%, a decrease of 99.11%. Total shares owned by institutions decreased in the last three months by 88.40% to 120K shares.
SenesTech Background Information
(This description is provided by the company.)
SenesTech is changing the model for pest management by targeting one of the root causes of the problem: reproduction. ContraPest® is an innovative technology with an approach that targets the reproductive capabilities of both sexes in rat populations, inducing egg loss in female rats and impairing sperm development in males. Using a proprietary bait delivery method, ContraPest® is dispensed in a highly palatable liquid formulation that promotes sustained consumption by rat communities. ContraPest® is designed, formulated and dispensed to be low hazard for handlers and non-target species such as wildlife, livestock and pets, where the active ingredients break down rapidly.
See all SenesTech regulatory filings.This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
